Article
Gene therapy for age-related macular degeneration
20 Jul 2017
Abstract excerpt
INTRODUCTION: In neovascular age related macular degeneration (nAMD), gene therapy to chronically express anti-vascular endothelial growth factor (VEGF) proteins could ameliorate the treatment burden of chronic intravitreal therapy and improve limited visual outcomes associated with 'real world' undertreatment. Areas covered: In this review, the authors assess the evolution of gene therapy for AMD....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
